Published in Nat Cell Biol on September 05, 2010
Molecular mechanisms of epithelial-mesenchymal transition. Nat Rev Mol Cell Biol (2014) 10.04
Regulatory networks defining EMT during cancer initiation and progression. Nat Rev Cancer (2013) 6.13
The epigenetics of epithelial-mesenchymal plasticity in cancer. Nat Med (2013) 3.96
Antiangiogenic agents increase breast cancer stem cells via the generation of tumor hypoxia. Proc Natl Acad Sci U S A (2012) 3.21
Unravelling cancer stem cell potential. Nat Rev Cancer (2013) 3.06
Signaling mechanisms of the epithelial-mesenchymal transition. Sci Signal (2014) 2.42
Normal and disease-related biological functions of Twist1 and underlying molecular mechanisms. Cell Res (2011) 1.99
Epithelial-mesenchymal transition and cancer stem cells: a dangerously dynamic duo in breast cancer progression. Breast Cancer Res (2011) 1.96
Phenotypic plasticity and epithelial-mesenchymal transitions in cancer and normal stem cells? Int J Cancer (2011) 1.79
Biomarkers of epithelial-mesenchymal transition in squamous cell carcinoma. J Dent Res (2012) 1.69
RAC1 activation mediates Twist1-induced cancer cell migration. Nat Cell Biol (2012) 1.69
The cancer stem cell niche: how essential is the niche in regulating stemness of tumor cells? Cell Stem Cell (2015) 1.66
Epithelial to mesenchymal transition in head and neck squamous cell carcinoma. Oral Oncol (2012) 1.60
MicroRNA-194 inhibits epithelial to mesenchymal transition of endometrial cancer cells by targeting oncogene BMI-1. Mol Cancer (2011) 1.59
Oncogenicity of the developmental transcription factor Sox9. Cancer Res (2012) 1.55
Functional cooperation between Snail1 and twist in the regulation of ZEB1 expression during epithelial to mesenchymal transition. J Biol Chem (2011) 1.45
Jak2-Stat5a/b Signaling Induces Epithelial-to-Mesenchymal Transition and Stem-Like Cell Properties in Prostate Cancer. Am J Pathol (2015) 1.44
Temporal and spatial cooperation of Snail1 and Twist1 during epithelial-mesenchymal transition predicts for human breast cancer recurrence. Mol Cancer Res (2011) 1.42
The F-box protein Ppa is a common regulator of core EMT factors Twist, Snail, Slug, and Sip1. J Cell Biol (2011) 1.40
Transcription factor SPZ1 promotes TWIST-mediated epithelial-mesenchymal transition and oncogenesis in human liver cancer. Oncogene (2017) 1.39
Regulation of epithelial-mesenchymal and mesenchymal-epithelial transitions by microRNAs. Curr Opin Cell Biol (2013) 1.39
The regulation of cell-cell adhesion during epithelial-mesenchymal transition, motility and tumor progression. Cell Adh Migr (2012) 1.34
Antagonism of miR-21 reverses epithelial-mesenchymal transition and cancer stem cell phenotype through AKT/ERK1/2 inactivation by targeting PTEN. PLoS One (2012) 1.32
ZEB1 drives prometastatic actin cytoskeletal remodeling by downregulating miR-34a expression. J Clin Invest (2012) 1.29
The biology of head and neck cancer stem cells. Oral Oncol (2011) 1.25
Epithelial mesenchymal transition in drug resistance and metastasis of lung cancer. Cancer Res Treat (2012) 1.24
MicroRNAs in the imprinted DLK1-DIO3 region repress the epithelial-to-mesenchymal transition by targeting the TWIST1 protein signaling network. J Biol Chem (2012) 1.23
CD133/Src axis mediates tumor initiating property and epithelial-mesenchymal transition of head and neck cancer. PLoS One (2011) 1.23
The Regulatory Role of MicroRNAs in EMT and Cancer. J Oncol (2015) 1.22
MicroRNA-708 induces apoptosis and suppresses tumorigenicity in renal cancer cells. Cancer Res (2011) 1.21
Epigenetic plasticity: a central regulator of epithelial-to-mesenchymal transition in cancer. Oncotarget (2014) 1.19
AP4 is a mediator of epithelial-mesenchymal transition and metastasis in colorectal cancer. J Exp Med (2013) 1.19
Tumorigenesis: Twist1 links EMT to self-renewal. Nat Cell Biol (2010) 1.17
Integrin αv expression is required for the acquisition of a metastatic stem/progenitor cell phenotype in human prostate cancer. Am J Pathol (2011) 1.16
Twist1 suppresses senescence programs and thereby accelerates and maintains mutant Kras-induced lung tumorigenesis. PLoS Genet (2012) 1.15
A KRAS-directed transcriptional silencing pathway that mediates the CpG island methylator phenotype. Elife (2014) 1.12
Induction of the neural crest state: control of stem cell attributes by gene regulatory, post-transcriptional and epigenetic interactions. Dev Biol (2012) 1.11
EMT and induction of miR-21 mediate metastasis development in Trp53-deficient tumours. Sci Rep (2012) 1.10
Bmi1 regulates self-renewal and epithelial to mesenchymal transition in breast cancer cells through Nanog. BMC Cancer (2014) 1.09
Mesenchymal and stemness circulating tumor cells in early breast cancer diagnosis. BMC Cancer (2012) 1.07
The histone methyltransferase MMSET/WHSC1 activates TWIST1 to promote an epithelial-mesenchymal transition and invasive properties of prostate cancer. Oncogene (2012) 1.07
TWIST1 is expressed in colorectal carcinomas and predicts patient survival. PLoS One (2011) 1.06
Signaling circuitries controlling stem cell fate: to be or not to be. Curr Opin Cell Biol (2011) 1.06
TCF12 protein functions as transcriptional repressor of E-cadherin, and its overexpression is correlated with metastasis of colorectal cancer. J Biol Chem (2011) 1.05
Cell adhesion and its endocytic regulation in cell migration during neural development and cancer metastasis. Int J Mol Sci (2012) 1.04
The aldehyde dehydrogenase enzyme 7A1 is functionally involved in prostate cancer bone metastasis. Clin Exp Metastasis (2011) 1.03
Polycomb proteins control proliferation and transformation independently of cell cycle checkpoints by regulating DNA replication. Nat Commun (2014) 1.03
T-box transcription factor Brachyury expression is correlated with epithelial-mesenchymal transition and lymph node metastasis in oral squamous cell carcinoma. Int J Oncol (2012) 1.02
Repositioning chloroquine and metformin to eliminate cancer stem cell traits in pre-malignant lesions. Drug Resist Updat (2011) 1.01
miR-186 regulation of Twist1 and ovarian cancer sensitivity to cisplatin. Oncogene (2015) 1.00
Loss of corepressor PER2 under hypoxia up-regulates OCT1-mediated EMT gene expression and enhances tumor malignancy. Proc Natl Acad Sci U S A (2013) 1.00
Oct4 mediates tumor initiating properties in oral squamous cell carcinomas through the regulation of epithelial-mesenchymal transition. PLoS One (2014) 1.00
DOT1L cooperates with the c-Myc-p300 complex to epigenetically derepress CDH1 transcription factors in breast cancer progression. Nat Commun (2015) 1.00
Transcriptional and epigenetic regulation of KIAA1199 gene expression in human breast cancer. PLoS One (2012) 1.00
TWIST and ovarian cancer stem cells: implications for chemoresistance and metastasis. Oncotarget (2014) 0.99
Twist1 expression induced by sunitinib accelerates tumor cell vasculogenic mimicry by increasing the population of CD133+ cells in triple-negative breast cancer. Mol Cancer (2014) 0.99
CD44s signals the acquisition of the mesenchymal phenotype required for anchorage-independent cell survival in hepatocellular carcinoma. Br J Cancer (2013) 0.97
Epithelial-mesenchymal transition expression profiles as a prognostic factor for disease-free survival in hepatocellular carcinoma: Clinical significance of transforming growth factor-β signaling. Oncol Lett (2012) 0.96
Wounds that will not heal: pervasive cellular reprogramming in cancer. Am J Pathol (2013) 0.96
G9a is essential for EMT-mediated metastasis and maintenance of cancer stem cell-like characters in head and neck squamous cell carcinoma. Oncotarget (2015) 0.95
Snail1-dependent control of embryonic stem cell pluripotency and lineage commitment. Nat Commun (2014) 0.95
Bmi-1: At the crossroads of physiological and pathological biology. Genes Dis (2015) 0.95
The T-box transcription factor Brachyury regulates epithelial-mesenchymal transition in association with cancer stem-like cells in adenoid cystic carcinoma cells. BMC Cancer (2012) 0.95
Cancer stem cells, epithelial-mesenchymal transition, and drug resistance in high-grade ovarian serous carcinoma. Hum Pathol (2013) 0.95
Hypoxia-induced Bmi1 promotes renal tubular epithelial cell-mesenchymal transition and renal fibrosis via PI3K/Akt signal. Mol Biol Cell (2014) 0.95
Interplay of Stem Cell Characteristics, EMT, and Microtentacles in Circulating Breast Tumor Cells. Cancers (Basel) (2013) 0.94
Stemness as a cell default state. EMBO Rep (2012) 0.94
Sub-sets of cancer stem cells differ intrinsically in their patterns of oxygen metabolism. PLoS One (2013) 0.94
The role of epithelial plasticity in prostate cancer dissemination and treatment resistance. Cancer Metastasis Rev (2014) 0.94
Cyclin A2, Rho GTPases and EMT. Small GTPases (2012) 0.93
Twist and snai1 expression in pharyngeal squamous cell carcinoma stroma is related to cancer progression. BMC Cancer (2011) 0.93
Osteopontin promotes a cancer stem cell-like phenotype in hepatocellular carcinoma cells via an integrin-NF-κB-HIF-1α pathway. Oncotarget (2015) 0.93
Serine Protease Activation Essential for Endothelial-Mesenchymal Transition in Vascular Calcification. Circ Res (2015) 0.92
Oncogenic roles of Bmi1 and its therapeutic inhibition by histone deacetylase inhibitor in tongue cancer. Lab Invest (2014) 0.92
Phosphorylation of Nanog is essential to regulate Bmi1 and promote tumorigenesis. Oncogene (2013) 0.91
Prognostic Value of EMT-Circulating Tumor Cells in Metastatic Breast Cancer Patients Undergoing High-Dose Chemotherapy with Autologous Hematopoietic Stem Cell Transplantation. J Cancer (2012) 0.91
Tumorsphere as an effective in vitro platform for screening anti-cancer stem cell drugs. Oncotarget (2016) 0.91
Co-expression of putative stemness and epithelial-to-mesenchymal transition markers on single circulating tumour cells from patients with early and metastatic breast cancer. BMC Cancer (2014) 0.90
Identification of miR-30e* regulation of Bmi1 expression mediated by tumor-associated macrophages in gastrointestinal cancer. PLoS One (2013) 0.90
The non-coding transcriptome as a dynamic regulator of cancer metastasis. Cancer Metastasis Rev (2014) 0.89
Contribution of acidic melanoma cells undergoing epithelial-to-mesenchymal transition to aggressiveness of non-acidic melanoma cells. Clin Exp Metastasis (2014) 0.89
Context-dependent actions of Polycomb repressors in cancer. Oncogene (2015) 0.89
Metastatic cancer stem cells: from the concept to therapeutics. Am J Stem Cells (2014) 0.89
The inflammatory tumor microenvironment, epithelial mesenchymal transition and lung carcinogenesis. Cancer Microenviron (2011) 0.89
Interplay between Homeobox proteins and Polycomb repressive complexes in p16INK⁴a regulation. EMBO J (2013) 0.89
DLX4 upregulates TWIST and enhances tumor migration, invasion and metastasis. Int J Biol Sci (2012) 0.89
Artemin stimulates radio- and chemo-resistance by promoting TWIST1-BCL-2-dependent cancer stem cell-like behavior in mammary carcinoma cells. J Biol Chem (2012) 0.88
New Insights into the Crossroads between EMT and Stemness in the Context of Cancer. J Clin Med (2016) 0.88
Bmi-1 induces radioresistance in MCF-7 mammary carcinoma cells. Oncol Rep (2011) 0.87
Recently identified biomarkers that promote lymph node metastasis in head and neck squamous cell carcinoma. Cancers (Basel) (2011) 0.86
Epithelial mesenchymal transition: a new insight into the detection of circulating tumor cells. ISRN Oncol (2012) 0.86
The role of epithelial-mesenchymal transition in pancreatic cancer. J Gastrointest Oncol (2011) 0.86
Inducible knockout of Twist1 in young and adult mice prolongs hair growth cycle and has mild effects on general health, supporting Twist1 as a preferential cancer target. Am J Pathol (2013) 0.86
A new role for the PI3K/Akt signaling pathway in the epithelial-mesenchymal transition. Cell Adh Migr (2015) 0.85
EMT and stem cell-like properties associated with HIF-2α are involved in arsenite-induced transformation of human bronchial epithelial cells. PLoS One (2012) 0.85
TCF12 is mutated in anaplastic oligodendroglioma. Nat Commun (2015) 0.85
High TWIST1 mRNA expression is associated with poor prognosis in lymph node-negative and estrogen receptor-positive human breast cancer and is co-expressed with stromal as well as ECM related genes. Breast Cancer Res (2012) 0.84
Down-regulation of miR-129-5p via the Twist1-Snail feedback loop stimulates the epithelial-mesenchymal transition and is associated with poor prognosis in breast cancer. Oncotarget (2015) 0.84
Bmi1 regulates auditory hair cell survival by maintaining redox balance. Cell Death Dis (2015) 0.83
CD44+ Cells in Head and Neck Squamous Cell Carcinoma Suppress T-Cell-Mediated Immunity by Selective Constitutive and Inducible Expression of PD-L1. Clin Cancer Res (2016) 0.83
The epithelial-mesenchymal transition generates cells with properties of stem cells. Cell (2008) 46.08
Epithelial-mesenchymal transitions in development and disease. Cell (2009) 39.17
Twist, a master regulator of morphogenesis, plays an essential role in tumor metastasis. Cell (2004) 31.38
ALDH1 is a marker of normal and malignant human mammary stem cells and a predictor of poor clinical outcome. Cell Stem Cell (2007) 22.89
Histone methyltransferase activity of a Drosophila Polycomb group repressor complex. Cell (2002) 13.05
The oncogene and Polycomb-group gene bmi-1 regulates cell proliferation and senescence through the ink4a locus. Nature (1999) 12.60
Drosophila enhancer of Zeste/ESC complexes have a histone H3 methyltransferase activity that marks chromosomal Polycomb sites. Cell (2002) 12.28
Identification of a subpopulation of cells with cancer stem cell properties in head and neck squamous cell carcinoma. Proc Natl Acad Sci U S A (2007) 11.94
Bmi-1 dependence distinguishes neural stem cell self-renewal from progenitor proliferation. Nature (2003) 11.23
Bmi1 is expressed in vivo in intestinal stem cells. Nat Genet (2008) 10.22
Epigenetic stem cell signature in cancer. Nat Genet (2006) 9.62
Regulation of hypoxia-inducible factor 1alpha is mediated by an O2-dependent degradation domain via the ubiquitin-proteasome pathway. Proc Natl Acad Sci U S A (1998) 9.56
Generation of breast cancer stem cells through epithelial-mesenchymal transition. PLoS One (2008) 8.97
The EMT-activator ZEB1 promotes tumorigenicity by repressing stemness-inhibiting microRNAs. Nat Cell Biol (2009) 8.63
Stem cells and cancer; the polycomb connection. Cell (2004) 7.43
Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol (2008) 7.37
Hypoxia requires notch signaling to maintain the undifferentiated cell state. Dev Cell (2005) 7.07
The Polycomb group proteins bind throughout the INK4A-ARF locus and are disassociated in senescent cells. Genes Dev (2007) 6.77
Hypoxia-inducible factors, stem cells, and cancer. Cell (2007) 5.96
Structural basis for specific binding of Polycomb chromodomain to histone H3 methylated at Lys 27. Genes Dev (2003) 5.77
Notch signalling regulates stem cell numbers in vitro and in vivo. Nature (2006) 5.49
EGFR, p16, HPV Titer, Bcl-xL and p53, sex, and smoking as indicators of response to therapy and survival in oropharyngeal cancer. J Clin Oncol (2008) 5.46
Bmi-1 collaborates with c-Myc in tumorigenesis by inhibiting c-Myc-induced apoptosis via INK4a/ARF. Genes Dev (1999) 5.35
Notch promotes epithelial-mesenchymal transition during cardiac development and oncogenic transformation. Genes Dev (2003) 4.89
Bmi1 is essential for cerebellar development and is overexpressed in human medulloblastomas. Nature (2004) 4.82
Single-cell cloning of colon cancer stem cells reveals a multi-lineage differentiation capacity. Proc Natl Acad Sci U S A (2008) 4.60
Snail mediates E-cadherin repression by the recruitment of the Sin3A/histone deacetylase 1 (HDAC1)/HDAC2 complex. Mol Cell Biol (2004) 4.15
Repression of E-cadherin by the polycomb group protein EZH2 in cancer. Oncogene (2008) 3.92
Ink4a and Arf differentially affect cell proliferation and neural stem cell self-renewal in Bmi1-deficient mice. Genes Dev (2005) 3.89
Patterns of gene expression during Drosophila mesoderm development. Science (2001) 3.48
Kaposi sarcoma herpesvirus-induced cellular reprogramming contributes to the lymphatic endothelial gene expression in Kaposi sarcoma. Nat Genet (2004) 3.38
Enhanced self-renewal of hematopoietic stem cells mediated by the polycomb gene product Bmi-1. Immunity (2004) 3.25
Polycomb complex 2 is required for E-cadherin repression by the Snail1 transcription factor. Mol Cell Biol (2008) 2.57
Aldehyde dehydrogenase 1 is a putative marker for cancer stem cells in head and neck squamous cancer. Biochem Biophys Res Commun (2009) 2.57
E-Cadherin gene promoter hypermethylation in primary human gastric carcinomas. J Natl Cancer Inst (2000) 2.05
The LIM protein AJUBA recruits protein arginine methyltransferase 5 to mediate SNAIL-dependent transcriptional repression. Mol Cell Biol (2008) 2.00
TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development. Cell Cycle (2008) 1.97
State-of-the-art management of locally advanced head and neck cancer. Br J Cancer (2005) 1.80
Elevated Bmi-1 expression is associated with dysplastic cell transformation during oral carcinogenesis and is required for cancer cell replication and survival. Br J Cancer (2006) 1.71
Gene expression profiling of human prostate cancer stem cells reveals a pro-inflammatory phenotype and the importance of extracellular matrix interactions. Genome Biol (2008) 1.62
The polycomb gene product BMI1 contributes to the maintenance of tumor-initiating side population cells in hepatocellular carcinoma. Cancer Res (2008) 1.56
Oncoprotein Bmi-1 renders apoptotic resistance to glioma cells through activation of the IKK-nuclear factor-kappaB Pathway. Am J Pathol (2009) 1.54
Overexpression of NBS1 induces epithelial-mesenchymal transition and co-expression of NBS1 and Snail predicts metastasis of head and neck cancer. Oncogene (2006) 1.52
Elongation inhibition by DRB sensitivity-inducing factor is regulated by the A20 promoter via a novel negative element and NF-kappaB. Mol Cell Biol (2004) 1.28
Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis. Neoplasia (2009) 1.22
Hypoxia in head and neck cancer: how much, how important? Head Neck (2005) 1.20
Functional network reconstruction reveals somatic stemness genetic maps and dedifferentiation-like transcriptome reprogramming induced by GATA2. Stem Cells (2008) 1.16
Tumor microenvironment in head and neck squamous cell carcinomas: predictive value and clinical relevance of hypoxic markers. A review. Head Neck (2007) 1.02
Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation. Clin Cancer Res (2006) 1.01
Co-expression of Bmi-1 and podoplanin predicts overall survival in patients with squamous cell carcinoma of the head and neck treated with radio(chemo)therapy. Int J Radiat Oncol Biol Phys (2009) 1.00
E-cadherin loss and Delta Np73L expression in oral squamous cell carcinomas showing aggressive behavior. Head Neck (2008) 0.85
Direct regulation of TWIST by HIF-1alpha promotes metastasis. Nat Cell Biol (2008) 7.37
In vitro hepatic differentiation of human mesenchymal stem cells. Hepatology (2004) 4.36
Amiodarone and the risk of cancer: a nationwide population-based study. Cancer (2013) 3.32
miR-31 ablates expression of the HIF regulatory factor FIH to activate the HIF pathway in head and neck carcinoma. Cancer Res (2010) 2.18
MicroRNA-146a directs the symmetric division of Snail-dominant colorectal cancer stem cells. Nat Cell Biol (2014) 2.13
Randomized controlled trial of entecavir prophylaxis for rituximab-associated hepatitis B virus reactivation in patients with lymphoma and resolved hepatitis B. J Clin Oncol (2013) 2.08
TWIST activation by hypoxia inducible factor-1 (HIF-1): implications in metastasis and development. Cell Cycle (2008) 1.97
Interplay between HDAC3 and WDR5 is essential for hypoxia-induced epithelial-mesenchymal transition. Mol Cell (2011) 1.94
Werner syndrome protein limits MYC-induced cellular senescence. Genes Dev (2003) 1.84
RAC1 activation mediates Twist1-induced cancer cell migration. Nat Cell Biol (2012) 1.69
SNAIL regulates interleukin-8 expression, stem cell-like activity, and tumorigenicity of human colorectal carcinoma cells. Gastroenterology (2011) 1.67
K15 protein of Kaposi's sarcoma-associated herpesvirus is latently expressed and binds to HAX-1, a protein with antiapoptotic function. J Virol (2002) 1.65
Rapid generation of mature hepatocyte-like cells from human induced pluripotent stem cells by an efficient three-step protocol. Hepatology (2012) 1.64
Pneumothorax after bevacizumab-containing chemotherapy: a case report. Jpn J Clin Oncol (2010) 1.62
p16(INK4A) promoter hypermethylation is associated with invasiveness and prognosis of oral squamous cell carcinoma in an age-dependent manner. Oral Oncol (2010) 1.61
A reappraisal of surgical management for squamous cell carcinoma in the pharyngoesophageal junction. J Surg Oncol (2006) 1.53
Epidermal growth factor receptor R521K polymorphism shows favorable outcomes in KRAS wild-type colorectal cancer patients treated with cetuximab-based chemotherapy. Cancer Sci (2012) 1.50
Temsirolimus enhances the efficacy of cetuximab in colon cancer through a CIP2A-dependent mechanism. J Cancer Res Clin Oncol (2014) 1.49
Intact INI1 gene region with paradoxical loss of protein expression in AT/RT: implications for a possible novel mechanism associated with absence of INI1 protein immunoreactivity. Am J Surg Pathol (2012) 1.48
Mesenchymal stem cells from human umbilical cord express preferentially secreted factors related to neuroprotection, neurogenesis, and angiogenesis. PLoS One (2013) 1.47
Endotoxin induces toll-like receptor 4 expression in vascular smooth muscle cells via NADPH oxidase activation and mitogen-activated protein kinase signaling pathways. Arterioscler Thromb Vasc Biol (2006) 1.45
Clinical features and prognostic factors of angioimmunoblastic T-cell lymphoma in Taiwan: a single-institution experience. Leuk Lymphoma (2010) 1.44
Cetuximab-based therapy in recurrent/metastatic head and neck squamous cell carcinoma: experience from an area in which betel nut chewing is popular. J Chin Med Assoc (2010) 1.43
Epigenetic reprogramming and post-transcriptional regulation during the epithelial-mesenchymal transition. Trends Genet (2012) 1.39
Stromal cell-derived factor-1 alpha promotes neuroprotection, angiogenesis, and mobilization/homing of bone marrow-derived cells in stroke rats. J Pharmacol Exp Ther (2007) 1.34
The role of human antigen R, an RNA-binding protein, in mediating the stabilization of toll-like receptor 4 mRNA induced by endotoxin: a novel mechanism involved in vascular inflammation. Arterioscler Thromb Vasc Biol (2006) 1.33
Regulation of excision repair cross-complementation group 1 by Snail contributes to cisplatin resistance in head and neck cancer. Clin Cancer Res (2010) 1.30
Epigenetic control of MHC class II expression in tumor-associated macrophages by decoy receptor 3. Blood (2008) 1.28
Extra-major salivary gland pleomorphic adenoma of the head and neck: a 10-year experience and review of the literature. Eur Arch Otorhinolaryngol (2010) 1.28
Enhancement of neuroplasticity through upregulation of beta1-integrin in human umbilical cord-derived stromal cell implanted stroke model. Neurobiol Dis (2007) 1.28
Design, synthesis, and preclinical evaluation of new 5,6- (or 6,7-) disubstituted-2-(fluorophenyl)quinolin-4-one derivatives as potent antitumor agents. J Med Chem (2010) 1.28
Importin KPNA2 is required for proper nuclear localization and multiple functions of NBS1. J Biol Chem (2005) 1.24
Hypoxia-regulated target genes implicated in tumor metastasis. J Biomed Sci (2012) 1.23
Mesenchymal stem cells promote formation of colorectal tumors in mice. Gastroenterology (2011) 1.23
Regulation of membrane-type 4 matrix metalloproteinase by SLUG contributes to hypoxia-mediated metastasis. Neoplasia (2009) 1.22
Functional module analysis reveals differential osteogenic and stemness potentials in human mesenchymal stem cells from bone marrow and Wharton's jelly of umbilical cord. Stem Cells Dev (2010) 1.21
LIM domains-containing protein 1 (LIMD1), a tumor suppressor encoded at chromosome 3p21.3, binds pRB and represses E2F-driven transcription. Proc Natl Acad Sci U S A (2004) 1.20
Pyogenic liver abscess as the initial manifestation of underlying hepatocellular carcinoma. Am J Med (2011) 1.19
Inhibition of tumorigenicity and enhancement of radiochemosensitivity in head and neck squamous cell cancer-derived ALDH1-positive cells by knockdown of Bmi-1. Oral Oncol (2009) 1.17
Overexpression of hTERT increases stem-like properties and decreases spontaneous differentiation in human mesenchymal stem cell lines. J Biomed Sci (2010) 1.16
Functional network reconstruction reveals somatic stemness genetic maps and dedifferentiation-like transcriptome reprogramming induced by GATA2. Stem Cells (2008) 1.16
c-Myc directly regulates the transcription of the NBS1 gene involved in DNA double-strand break repair. J Biol Chem (2003) 1.14
Soft tissue sarcoma of extremities: the prognostic significance of adequate surgical margins in primary operation and reoperation after recurrence. Ann Surg Oncol (2010) 1.14
The manipulation of miRNA-gene regulatory networks by KSHV induces endothelial cell motility. Blood (2011) 1.13
Bmi-1 Regulates Snail Expression and Promotes Metastasis Ability in Head and Neck Squamous Cancer-Derived ALDH1 Positive Cells. J Oncol (2010) 1.13
Kaposi sarcoma herpesvirus-encoded vFLIP and vIRF1 regulate antigen presentation in lymphatic endothelial cells. Blood (2006) 1.12
Implant placement immediately after the lateral approach of the trap door window procedure to create a maxillary sinus lift without bone grafting: a 2-year retrospective evaluation of 47 implants in 33 patients. J Oral Maxillofac Surg (2007) 1.08
Secretoneurin promotes neuroprotection and neuronal plasticity via the Jak2/Stat3 pathway in murine models of stroke. J Clin Invest (2008) 1.08
MicroRNA-200c attenuates tumour growth and metastasis of presumptive head and neck squamous cell carcinoma stem cells. J Pathol (2011) 1.08
Activation of the Notch1/STAT3/Twist signaling axis promotes gastric cancer progression. Carcinogenesis (2012) 1.07
Combination of microarray profiling and protein-protein interaction databases delineates the minimal discriminators as a metastasis network for esophageal squamous cell carcinoma. Int J Oncol (2009) 1.07
The M type K15 protein of Kaposi's sarcoma-associated herpesvirus regulates microRNA expression via its SH2-binding motif to induce cell migration and invasion. J Virol (2008) 1.06
miR-134 induces oncogenicity and metastasis in head and neck carcinoma through targeting WWOX gene. Int J Cancer (2013) 1.06
Outcomes of oral squamous cell carcinoma in Taiwan after surgical therapy: factors affecting survival. J Oral Maxillofac Surg (2003) 1.06
The implication of osteopontin (OPN) expression and genetic polymorphisms of OPN promoter in oral carcinogenesis. Oral Oncol (2010) 1.05
easyExon--a Java-based GUI tool for processing and visualization of Affymetrix exon array data. BMC Bioinformatics (2008) 1.05
Influence of GSTP1 I105V polymorphism on cumulative neuropathy and outcome of FOLFOX-4 treatment in Asian patients with colorectal carcinoma. Cancer Sci (2009) 1.04
Chromosome instability modulated by BMI1-AURKA signaling drives progression in head and neck cancer. Cancer Res (2012) 1.04
YM500: a small RNA sequencing (smRNA-seq) database for microRNA research. Nucleic Acids Res (2012) 1.04
Krüppel-like transcription factor 4 contributes to maintenance of telomerase activity in stem cells. Stem Cells (2010) 1.03
A nation-wide analysis of venous thromboembolism in 497,180 cancer patients with the development and validation of a risk-stratification scoring system. Thromb Haemost (2012) 1.03
Connective tissue growth factor activates pluripotency genes and mesenchymal-epithelial transition in head and neck cancer cells. Cancer Res (2013) 1.03
CIP2A is a predictor of poor prognosis in colon cancer. J Gastrointest Surg (2012) 1.03
ArrayFusion: a web application for multi-dimensional analysis of CGH, SNP and microarray data. Bioinformatics (2006) 1.02
Involvement of topoisomerase III in telomere-telomere recombination. J Biol Chem (2006) 1.02
miR-146a-5p circuitry uncouples cell proliferation and migration, but not differentiation, in human mesenchymal stem cells. Nucleic Acids Res (2013) 1.02
Isolation and characterization of multi-potent stem cells from human orbital fat tissues. Tissue Eng Part A (2010) 1.01
The association between genetic polymorphism and the processing efficiency of miR-149 affects the prognosis of patients with head and neck squamous cell carcinoma. PLoS One (2012) 1.01
Increased NBS1 expression is a marker of aggressive head and neck cancer and overexpression of NBS1 contributes to transformation. Clin Cancer Res (2006) 1.01
Removal of unapproachable laryngopharyngeal foreign bodies under flexible videolaryngoscopy. Laryngoscope (2003) 1.01
Direct activation of HSP90A transcription by c-Myc contributes to c-Myc-induced transformation. J Biol Chem (2004) 1.00
Prognostic significance of a pretreatment hematologic profile in patients with head and neck cancer. J Cancer Res Clin Oncol (2009) 1.00